Unlike CXCL4, CXCL4L1 did not bind to CCL5 and did not enhance atherosclerosis in transgenic mice with CXCL4 modified to CXCL4L1, indicating that CXCL4L1 has reduced inflammatory potential, at least during plaque development [29]. This evidence concerns the gene CCL5 and atherosclerosis.